Marqibo

Entity type image
Type: Product
Name: Marqibo
First reported Jun 14 2013 - Updated Jun 14 2013 - 1 reports

Tekmira Pharmaceuticals: An Interesting Long-Term Investment

Home » Blogs » Tekmira Pharmaceuticals (TKMR) is a small-cap pharmaceutical company with a very interesting pipeline. The company has many different drugs in many stages of development. As these drugs progress, so too should the stock price at Tekmira. ... [Published BioPortfolio - Jun 14 2013]
First reported Jun 13 2013 - Updated Jun 13 2013 - 1 reports

Tekmira Pharmaceuticals: An Interesting Long-Term Investment

Tekmira Pharmaceuticals (TKMR) is a small-cap pharmaceutical company with a very interesting pipeline. The company has many different drugs in many stages of development. As these drugs progress, so too should the stock price at Tekmira. Tekmira represents ... [Published Seeking Alpha - Jun 13 2013]
First reported Apr 01 2013 - Updated Apr 01 2013 - 1 reports

Talon Therapeutics, Inc. Reports Fourth Quarter and Year End 2012 Financial Results

Unaudited Financial ResultsFor the three months ended December 31, 2012, the Company reported net income of $7.1 million and deemed dividends on preferred stock of $3.2 million, which when combined, resulted in net income applicable to common stockholders ... [Published Stockwatch - Apr 01 2013]
First reported Jan 16 2013 - Updated Jan 16 2013 - 1 reports

MARQIBO (Vincristine Sulfate) Kit [Talon Therapeutics, Inc]

Updated Date: Jan 14, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Jan 16 2013]
First reported Jan 14 2013 - Updated Jan 15 2013 - 2 reports

MARQIBO (Vincristine Sulfate) Kit [Talon Therapeutics, Inc]

Updated Date: Jan 14, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Jan 15 2013]

Quotes

...Unfortunately, Marqibo is not currently on the market as Talon is awaiting a marketing partner for the product, saying in its most that: "Marqibo, based on its initial label, is a niche product with ongoing research and development activities focused on potential future label expansion opportunities and upside primarily linked to the optimal greater than 60 steady and a lymphoma indication. On our last investor call, I stated that it was more likely than not that Marqibo would be launched following a transaction. This company stamp remains." The fact that Marqibo has been approved but is currently not on the market is hurting Tekmira...
Tekmira Pharmaceuticals: An Interesting Long-Term Investment [Published Seeking Alpha - Jun 13 2013]
...is Talon's most important achievement to date," stated Steven R Deitcher, M D , President, Chief Executive Officer and Board Member of Talon. "The patient population Marqibo$ will be serving is in need of new treatment options. We are in the process of evaluating a number of paths to commercialize Marqibo$, including a potential strategic transaction, licensing agreement, or a Talon launch."
Talon Therapeutics, Inc. Reports Third Quarter 2012 Financial Results [Published GlobeNewswire - Nov 14 2012]

More Content

All (9) | News (3) | Reports (1) | Blogs (5) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Tekmira Pharmaceuticals: An Interesting Long-Te... [Published BioPortfolio - Jun 14 2013]
Tekmira Pharmaceuticals: An Interesting Long-Te... [Published Seeking Alpha - Jun 13 2013]
Talon Therapeutics, Inc. Reports Fourth Quarter... [Published Stockwatch - Apr 01 2013]
InPlay from Briefing.com [Published MaritimeSecurity.Asia - Feb 13 2013]
A Big Year for Novel Drugs Approvals [Published I Am Biotech - Jan 17 2013]
MARQIBO (Vincristine Sulfate) Kit [Talon Therap... [Published DailyMed Drug Label Updates for the last seven ... - Jan 16 2013]
MARQIBO (Vincristine Sulfate) Kit [Talon Therap... [Published DailyMed Drug Label Updates for the last seven ... - Jan 15 2013]
MARQIBO (Vincristine Sulfate) Kit [Talon Therap... [Published DailyMed Drug Label Updates for the last seven ... - Jan 14 2013]
Talon Therapeutics, Inc. Reports Third Quarter ... [Published GlobeNewswire - Nov 14 2012]
1
In Focus
  •  
Steven R Deitcher, Patrick Byrne, Michael Kors, [more]
  •  
Talon Therapeutics Inc, Tekmira Pharmaceuticals Corporation, Hana Biosciences Inc, [more]
  •  
European Medicines Agency, FDA Food & Drug Administration, National Hockey League, [more]
  •  
Vincristine Sulfate, Acute Lymphoblastic Leukemia, hepatic, [more]
  •  
Vfend, The Lancet, Omontys, [more]
  •  
Philadelphia (Pennsylvania, United States), South San Francisco (United States), San Mateo (United States), [more]
  •  
United States, China, Japan, [more]
  •  
Diseases, Medication, Research & Development, [more]
  •  
Pharma & Biotech
DailyMed Drug Label Updates for the last seven ..., Stockwatch, GlobeNewswire, [more]
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
InPlay from Briefing.com [Published MaritimeSecurity.Asia - Feb 13 2013]
7:02 pm Limoneira announces the annexation of East Area 1 into the city of Santa Paula ( LMNR ) : Co announced that on February 12, 2013, East Area 1 was formally annexed into Santa Paula. The annexation was the final required step to enable Limoneira ...
A Big Year for Novel Drugs Approvals [Published I Am Biotech - Jan 17 2013]
What was your top Biopharma highlight for 2012? If it wasn’t the stellar move in the AMEX Biotech Index (up 42%), or the reauthorization of PDUFA, then perhaps it was the decade high for innovative drugs approvals. We would need to go back to the 1990s ...
MARQIBO (Vincristine Sulfate) Kit [Talon Therap... [Published DailyMed Drug Label Updates for the last seven ... - Jan 16 2013]
Updated Date: Jan 14, 2013 EST ...
MARQIBO (Vincristine Sulfate) Kit [Talon Therap... [Published DailyMed Drug Label Updates for the last seven ... - Jan 15 2013]
Updated Date: Jan 14, 2013 EST ...
MARQIBO (Vincristine Sulfate) Kit [Talon Therap... [Published DailyMed Drug Label Updates for the last seven ... - Jan 14 2013]
Updated Date: Jan 14, 2013 EST ...
1
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.